Helmut Forstbauer
3PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 22, 2023
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial.Nadia Harbeck, Ulrike A Nitz, Matthias Christgen
|Nov 28, 2022
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial.Monika Graeser, Oleg Gluz, Claudia Biehl
|Apr 11, 2022
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer.Ulrike A Nitz, Oleg Gluz, Sherko Kümmel
Pageof 1
Frequent Collaborators
3 joint publications
Oleg Gluz
3 joint publications
Sherko Kümmel
3 joint publications
Matthias Christgen
3 joint publications
Nadia Harbeck
3 joint publications
Monika Gräser
2 joint publications
Bahriye Aktas
2 joint publications
Eva-Maria Grischke
2 joint publications
Hans Holger Fischer
2 joint publications
Wolfram Malter
2 joint publications
Michael Hauptmann
